Jefferies Raises Numbers on Myriad Genetics (MYGN)

November 6, 2012 12:54 PM

Jefferies maintained a Buy rating on Myriad Genetics (NASDAQ: MYGN) and raised its price target to $33.00 (from $31.00). Myriad ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found